Skip to content

Viking Therapeutics VKTX FX Effect on Cash

FX Effect on Cash at other companies

Eli Lilly logo
Eli LillyLLY
$67M-49.2%
Pfizer logo
PfizerPFE
$19M+371%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$1.32M
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$8K
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$1.41M+200%

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$4.04B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's FX effect on cash?
Viking Therapeutics (VKTX) reported FX effect on cash of $16K in Q1 2026.
How has Viking Therapeutics's FX effect on cash changed year-over-year?
Viking Therapeutics's FX effect on cash increased by 1500.0% year-over-year, from $1K to $16K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.